Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Inhibition of p300/CBP Overcomes BTK Inhibitor Resistance in MCL By Counteracting IL-6/JAK/STAT3 Signaling

Yusuke Tashiro, Kotaro Shirakawa, Hiroshi Arima, Ryosuke Nomura, Yoshihito Horisawa, Stanford Emani, Suguru Takeuchi, Jelagat Caroline, Yasuhiro Kazuma, Hiroyuki Matsui, Tadahiko Matsumoto, Kosuke Yusa, Akifumi Takaori-Kondo

Blood (2024) 144 (Supplement 1): 5843.

https://doi.org/10.1182/blood-2024-206382

Published: 2024

Journal Articles

Inhibition of Lysine Acetyltransferases p300/CBP Overcomes BTK Inhibitor Resistance in Mantle Cell Lymphoma Cells

Yusuke Tashiro, Kotaro Shirakawa, Ryosuke Nomura, Yoshihito Horisawa, Stanford Emani, Suguru Takeuchi, Jelagat Caroline, Yasuhiro Kazuma, Kosuke Yusa, Akifumi Takaori-Kondo

Blood (2023) 142 (Supplement 1): 2816.

https://doi.org/10.1182/blood-2023-179993

Published: 2023

Journal Articles

CNOT4 Knockout Induces Proteasome Inhibitor Resistance in Multiple Myeloma Cells

Yoshihito Horisawa, Kotaro Shirakawa, Suguru Takeuchi, Ryosuke Nomura, Yusuke Tashiro, Stanford Emani, Jelagat Caroline, Yasuhiro Kazuma, Kosuke Yusa, Akifumi Takaori-Kondo

Blood (2023) 142 (Supplement 1): 1444.

https://doi.org/10.1182/blood-2023-185862

Published: 2023

Journal Articles

Interactome Analysis of APOBEC3B in Multiple Myeloma

Yasuhiro Kazuma, MD, Kotaro Shirakawa, MD PhD, Anamaria Daniela Sarca, MD, Yoshihito Horisawa, MD, Hirofumi Fukuda, MD, Hiroyuki Matsui, MD, Hiroyuki Yamazaki, MD, Tadahiko Matsumoto, MD, Fumiko Tanabe, Ryo Morishita, PhD, Shinji Ito, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 1259.

https://doi.org/10.1182/blood-2019-126856

Published: 2019

Journal Articles

Selective HDAC3 Inhibition Induces Apoptosis in B Cell Lymphoma through Protein Acetylation

Hiroyuki Matsui, MD, Kotaro Shirakawa, MD PhD, Hsin-Yi Chang, PhD, Anamaria Daniela Sarca, MD, Yasuhiro Kazuma, MD, Hirofumi Fukuda, MD, Hiroyuki Yamazaki, MD, Tadahiko Matsumoto, MD, Yasushi Ishihama, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2018) 132 (Supplement 1): 1583.

https://doi.org/10.1182/blood-2018-99-112853

Published: 2018

Journal Articles

PKA-Mediated Phosphorylation of APOBEC3B Suppresses Its DNA Mutagenic Potential in Myeloma Cells

Tadahiko Matsumoto, MD, Kotaro Shirakawa, MD PhD, Hiroyuki Matsui, MD, Hiroyuki Yamazaki, MD, Yasuhiro Kazuma, MD, Anamaria Daniela Sarca, MD, Hirofumi Fukuda, MD, Wataru Maruyama, MD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 4427.

https://doi.org/10.1182/blood.V128.22.4427.4427

Published: 2016

Journal Articles

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Yasuhiro Kazuma, MD, Kazunari Aoki, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yosuke Nagahata, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 3030.

https://doi.org/10.1182/blood.V124.21.3030.3030

Published: 2014

Journal Articles

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2962.

https://doi.org/10.1182/blood.V124.21.2962.2962

Published: 2014

Journal Articles

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

Yotaro Ochi, MD, Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Megumu Hino, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 1647.

https://doi.org/10.1182/blood.V124.21.1647.1647

Published: 2014

Journal Articles

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Yosuke Nagahata, MD, Yoshimitsu Shimomura, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2298.

https://doi.org/10.1182/blood.V124.21.2298.2298

Published: 2014

Journal Articles

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Yuichiro Ono, M.D., June Takeda, M.D., Hayato Maruoka, Yasuhiro Kazuma, M.D., Nobuhiro Hiramoto, MD, Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yuki Funayama, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Koji Nasu, Takayuki Takahashi, M.D., Ph.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3921.

https://doi.org/10.1182/blood.V122.21.3921.3921

Published: 2013

Journal Articles

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

June Takeda, M.D., Nobuhiko Yamauchi, M.D., Kazunari Aoki, MD, Yuichiro Ono, M.D., Yuki Funayama, M.D., Yasuhiro Kazuma, M.D., Yosuke Nagahata, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Nobuhiro Hiramoto, M.D., Akiko Matsushita, M.D., Noboru Yonetani, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 5215.

https://doi.org/10.1182/blood.V122.21.5215.5215

Published: 2013

Journal Articles

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

Yosuke Nagahata, M.D., Yuichiro Ono, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, M.D., June Takeda, M.D., Yuki Funayama, M.D., Nobuhiko Yamauchi, M.D., Nobuhiro Hiramoto, M.D., Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 2166.

https://doi.org/10.1182/blood.V122.21.2166.2166

Published: 2013

Journal Articles

M-Protein Is Associated With Aggressive Disease In Patients With MALT Lymphoma

Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yasuhiro Kazuma, M.D., June Takeda, M.D., Yuki Funayama, M.D., Yuichiro Ono, M.D., Nobuhiro Hiramoto, M.D., Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3008.

https://doi.org/10.1182/blood.V122.21.3008.3008

Published: 2013

NARROW

Inhibition of p300/CBP Overcomes BTK Inhibitor Resistance in MCL By Counteracting IL-6/JAK/STAT3 Signaling

Inhibition of Lysine Acetyltransferases p300/CBP Overcomes BTK Inhibitor Resistance in Mantle Cell Lymphoma Cells

CNOT4 Knockout Induces Proteasome Inhibitor Resistance in Multiple Myeloma Cells

Interactome Analysis of APOBEC3B in Multiple Myeloma

Selective HDAC3 Inhibition Induces Apoptosis in B Cell Lymphoma through Protein Acetylation

PKA-Mediated Phosphorylation of APOBEC3B Suppresses Its DNA Mutagenic Potential in Myeloma Cells

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

M-Protein Is Associated With Aggressive Disease In Patients With MALT Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only